Back to top
more

Brainsway (BWAY)

(Real Time Quote from BATS)

$4.92 USD

4.92
10,441

-0.11 (-2.19%)

Updated Apr 25, 2024 11:31 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (150 out of 251)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for BWAY

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

Brainsway Ltd. Sponsored ADR [BWAY]

Reports for Purchase

Showing records 1 - 20 ( 26 total )

Company: Brainsway Ltd. Sponsored ADR

Industry: Medical - Products

Record: 1

03/11/2024

Company Report

Pages: 4

Moderate 4Q23 Top- and Bottom-Line Beat; 2023 Financials; Raising PT to $13

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Company: Brainsway Ltd. Sponsored ADR

Industry: Medical - Products

Record: 2

12/11/2023

Company Report

Pages: 4

Deep TMS South Korean Expansion; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: PACHAIYAPPAN B

Price: 5.00

Research Provided by a Third Party

Company: Brainsway Ltd. Sponsored ADR

Industry: Medical - Products

Record: 3

11/21/2023

Company Report

Pages: 5

Top and Bottom-Line Beat; 3Q23 Financial Results; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: PACHAIYAPPAN B

Price: 5.00

Research Provided by a Third Party

Company: Brainsway Ltd. Sponsored ADR

Industry: Medical - Products

Record: 4

10/20/2023

Company Report

Pages: 7

Publication Indicates Accelerated Deep TMS Protocol Benefits; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: PACHAIYAPPAN B

Price: 12.50

Research Provided by a Third Party

Company: Brainsway Ltd. Sponsored ADR

Industry: Medical - Products

Record: 5

09/22/2023

Company Report

Pages: 5

Katie’s Way Plus Orders 10 New Deep TMS Systems; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: PACHAIYAPPAN B

Price: 5.00

Research Provided by a Third Party

Company: Brainsway Ltd. Sponsored ADR

Industry: Medical - Products

Record: 6

09/06/2023

Company Report

Pages: 4

Strategic Partnership Expansion Continues; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: PACHAIYAPPAN B

Price: 5.00

Research Provided by a Third Party

Company: Brainsway Ltd. Sponsored ADR

Industry: Medical - Products

Record: 7

08/24/2023

Company Report

Pages: 4

Deep TMS Commercial Footprint Expanded; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: PACHAIYAPPAN B

Price: 5.00

Research Provided by a Third Party

Company: Brainsway Ltd. Sponsored ADR

Industry: Medical - Products

Record: 8

08/21/2023

Company Report

Pages: 6

Top- and Bottom-Line Beat; 2Q23 Financial Results Reported; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: PACHAIYAPPAN B

Price: 12.50

Research Provided by a Third Party

Company: Brainsway Ltd. Sponsored ADR

Industry: Medical - Products

Record: 9

06/05/2023

Company Report

Pages: 5

Top-Line In-Line, Bottom-Line Beat; New Finance Head; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: PACHAIYAPPAN B

Price: 5.00

Research Provided by a Third Party

Company: Brainsway Ltd. Sponsored ADR

Industry: Medical - Products

Record: 10

04/13/2023

Company Report

Pages: 5

Leadership Transition; Financial Results Reported; Adjusting PT Down to $12

Provider: H.C. Wainwright & Co., Inc.

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Brainsway Ltd. Sponsored ADR

Industry: Medical - Products

Record: 11

02/01/2023

Company Report

Pages: 5

Publication Strengthens the Case For H7 Coil Use in MDD Patients; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Brainsway Ltd. Sponsored ADR

Industry: Medical - Products

Record: 12

12/12/2022

Company Report

Pages: 5

Negative Impact From Macro Headwinds; Lowering PT to $13

Provider: H.C. Wainwright & Co., Inc.

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Brainsway Ltd. Sponsored ADR

Industry: Medical - Products

Record: 13

09/19/2022

Company Report

Pages: 5

Deep TMS Coverage in Obsessive-Compulsive Disorder Expanded; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 5.00

Research Provided by a Third Party

Company: Brainsway Ltd. Sponsored ADR

Industry: Medical - Products

Record: 14

08/30/2022

Company Report

Pages: 5

H7 Coil Receives Second FDA Clearance in Depression; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 5.00

Research Provided by a Third Party

Company: Brainsway Ltd. Sponsored ADR

Industry: Medical - Products

Record: 15

08/22/2022

Company Report

Pages: 5

Favorable Reimbursement Decisions; 2Q22 Financial Results; Raising PT to $16

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 5.00

Research Provided by a Third Party

Company: Brainsway Ltd. Sponsored ADR

Industry: Medical - Products

Record: 16

07/05/2022

Company Report

Pages: 5

Deep TMS Holds High Value to Address Mental Health Disorders; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 5.00

Research Provided by a Third Party

Company: Brainsway Ltd. Sponsored ADR

Industry: Medical - Products

Record: 17

06/23/2022

Company Report

Pages: 4

Insurance Coverage Expansion; Solid Operating Performance; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 5.00

Research Provided by a Third Party

Company: Brainsway Ltd. Sponsored ADR

Industry: Medical - Products

Record: 18

02/01/2022

Company Report

Pages: 4

Deep TMS Coverage for OCD Treatment Expanded; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 5.00

Research Provided by a Third Party

Company: Brainsway Ltd. Sponsored ADR

Industry: Medical - Products

Record: 19

12/10/2021

Company Report

Pages: 5

Deep TMS Impact in Treating Alcohol Use Disorder; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 5.00

Research Provided by a Third Party

Company: Brainsway Ltd. Sponsored ADR

Industry: Medical - Products

Record: 20

11/29/2021

Company Report

Pages: 5

3Q21 Financial Results; Top- and Bottom-Line Beat; Raising PT to $15

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 5.00

Research Provided by a Third Party